logo
Plus   Neg
Share
Email

Kraton Says COVID-19 Has Had Limited Impact On Its Business And Results

Provided a status update related to the coronavirus (COVID-19) pandemic impact, Kraton Corp. (KRA) announced Monday that COVID-19 has had a limited impact on its business and results of operations as its plants have continued to operate at normal capacities, and its supply chain remains intact, with adequate availability of key raw materials.

The company continues to strengthen its balance sheet, most recently through the March 6, 2020 sale of its Cariflex business for $530 million, and the subsequent reduction in amounts outstanding under its senior secured term loan facility.

With the sale, the company expects to reduce consolidated net debt by approximately $480 million by the end of the first quarter of 2020. The company said it has no scheduled maturities until 2025, with the exception of the currently largely undrawn $250 million ABL facility.

For the first quarter of 2020, the company expects to report adjusted EBITDA exceeding the current consensus estimate of approximately $46 million. It also expects to release full results for the first quarter of 2020 after market close on April 29, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies. The U.S. Food and Drug Administration or FDA announced that Acella Pharmaceuticals, LLC recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency. The company is recalling 13 lots of NP Thyroid that are packaged in 100 count bottles in strengths of 30 mg, 60 mg, and 90 mg, with expiration dates between June 20, 2020, and December 20, 2020.
Follow RTT